uniQure N.V. (QURE) stock
QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30224% above fair value
$20.30−0.48 (-2.31%)
Close on Nov 18, 2026Market cap $1.41BP/E –Yield –
uniQure cash
Cash and short-term investments held at the end of each period.
uniQure's cash was $413.03M at Jun 30, 2026. For fiscal 2025 it was $80.24M, down 50.0% from the year before. Over ten years it grew -9.7% a year on average. The highest annual figure on record is $559.35M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $80.24M | -50.0% |
| FY2024 | Dec 31, 2024 | $160.33M | -33.6% |
| FY2023 | Dec 31, 2023 | $241.36M | +4.4% |
| FY2022 | Dec 31, 2022 | $231.17M | -58.7% |
| FY2021 | Dec 31, 2021 | $559.35M | +125.8% |
| FY2020 | Dec 31, 2020 | $247.68M | -34.9% |
| FY2019 | Dec 31, 2019 | $380.73M | +60.4% |
| FY2018 | Dec 31, 2018 | $237.34M | +46.6% |
| FY2017 | Dec 31, 2017 | $161.85M | +20.5% |
| FY2016 | Dec 31, 2016 | $134.32M | -39.7% |
| FY2015 | Dec 31, 2015 | $222.87M | +244.5% |
| FY2014 | Dec 31, 2014 | $64.69M | +97.4% |
| FY2013 | Dec 31, 2013 | $32.78M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $413.03M | +62.8% |
| Q1 FY2026 | Mar 31, 2026 | $139.99M | -35.6% |
| Q4 FY2025 | Dec 31, 2025 | $80.24M | -50.0% |
| Q3 FY2025 | Sep 30, 2025 | $597.06M | +137.3% |
| Q2 FY2025 | Jun 30, 2025 | $253.78M | -11.8% |
| Q1 FY2025 | Mar 31, 2025 | $217.23M | -10.6% |
| Q4 FY2024 | Dec 31, 2024 | $160.33M | -33.6% |
| Q3 FY2024 | Sep 30, 2024 | $251.63M | +9.6% |
| Q2 FY2024 | Jun 30, 2024 | $287.88M | -43.9% |
| Q1 FY2024 | Mar 31, 2024 | $243.06M | +58.0% |
| Q4 FY2023 | Dec 31, 2023 | $241.36M | +4.4% |
| Q3 FY2023 | Sep 30, 2023 | $229.48M | -47.9% |
| Q2 FY2023 | Jun 30, 2023 | $513.60M | +2.6% |
| Q1 FY2023 | Mar 31, 2023 | $153.85M | -70.7% |
| Q4 FY2022 | Dec 31, 2022 | $231.17M | -58.7% |
| Q3 FY2022 | Sep 30, 2022 | $440.31M | -23.9% |
| Q2 FY2022 | Jun 30, 2022 | $500.52M | -26.1% |
| Q1 FY2022 | Mar 31, 2022 | $524.89M | +101.2% |
| Q4 FY2021 | Dec 31, 2021 | $559.35M | +125.8% |
| Q3 FY2021 | Sep 30, 2021 | $578.46M | +107.0% |
| Q2 FY2021 | Jun 30, 2021 | $677.33M | +115.5% |
| Q1 FY2021 | Mar 31, 2021 | $260.81M | -23.7% |
| Q4 FY2020 | Dec 31, 2020 | $247.68M | -34.9% |
| Q3 FY2020 | Sep 30, 2020 | $279.49M | -30.7% |
| Q2 FY2020 | Jun 30, 2020 | $314.27M | +70.7% |
| Q1 FY2020 | Mar 31, 2020 | $342.03M | +63.8% |
| Q4 FY2019 | Dec 31, 2019 | $380.73M | +60.4% |
| Q3 FY2019 | Sep 30, 2019 | $403.16M | +68.3% |
| Q2 FY2019 | Jun 30, 2019 | $184.10M | -29.0% |
| Q1 FY2019 | Mar 31, 2019 | $208.79M | +48.3% |
| Q4 FY2018 | Dec 31, 2018 | $237.34M | +46.6% |
| Q3 FY2018 | Sep 30, 2018 | $239.55M | +169.4% |
| Q2 FY2018 | Jun 30, 2018 | $259.18M | +149.0% |
| Q1 FY2018 | Mar 31, 2018 | $140.82M | +17.1% |
| Q4 FY2017 | Dec 31, 2017 | $161.85M | +20.5% |
| Q3 FY2017 | Sep 30, 2017 | $88.93M | -43.6% |
| Q2 FY2017 | Jun 30, 2017 | $104.09M | – |
| Q1 FY2017 | Mar 31, 2017 | $120.27M | – |
| Q4 FY2016 | Dec 31, 2016 | $134.32M | – |
| Q3 FY2016 | Sep 30, 2016 | $157.55M | – |
See a number that looks wrong?